US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Theratechnologies Inc (THTX)
Theratechnologies Inc (THTX) ニュース

THTX

Theratechnologies (THTX)

Theratechnologies Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:THTX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/24	06 : 00	GlobeNewswire Inc.	Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors	NASDAQ:THTX	Theratechnologies Inc
2024/05/11	02 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/05/10	06 : 26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/05/10	05 : 30	GlobeNewswire Inc.	Theratechnologies Reports on its Annual Meeting of Shareholders	NASDAQ:THTX	Theratechnologies Inc
2024/05/02	20 : 30	GlobeNewswire Inc.	Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting	NASDAQ:THTX	Theratechnologies Inc
2024/04/16	05 : 15	GlobeNewswire Inc.	Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders	NASDAQ:THTX	Theratechnologies Inc
2024/04/11	20 : 30	GlobeNewswire Inc.	Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:THTX	Theratechnologies Inc
2024/04/10	20 : 30	GlobeNewswire Inc.	Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024	NASDAQ:THTX	Theratechnologies Inc
2024/04/10	20 : 15	IH Market News	U.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge Higher	NASDAQ:THTX	Theratechnologies Inc
2024/04/09	05 : 30	GlobeNewswire Inc.	Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform	NASDAQ:THTX	Theratechnologies Inc
2024/04/06	00 : 00	GlobeNewswire Inc.	Theratechnologies Appoints Elina Tea to its Board of Directors	NASDAQ:THTX	Theratechnologies Inc
2024/04/03	20 : 30	GlobeNewswire Inc.	Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update	NASDAQ:THTX	Theratechnologies Inc
2024/03/28	20 : 30	GlobeNewswire Inc.	Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform	NASDAQ:THTX	Theratechnologies Inc
2024/03/22	22 : 36	GlobeNewswire Inc.	Theratechnologies Announces Update on its Preclinical Oncology Research Program	NASDAQ:THTX	Theratechnologies Inc
2024/03/22	09 : 00	GlobeNewswire Inc.	Theratechnologies Appoints Jordan Zwick to its Board of Directors	NASDAQ:THTX	Theratechnologies Inc
2024/03/21	20 : 30	GlobeNewswire Inc.	Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer	NASDAQ:THTX	Theratechnologies Inc
2024/03/01	06 : 55	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/03/01	06 : 34	GlobeNewswire Inc.	Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau	NASDAQ:THTX	Theratechnologies Inc
2024/02/27	22 : 37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/27	21 : 30	GlobeNewswire Inc.	Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA	NASDAQ:THTX	Theratechnologies Inc
2024/02/21	22 : 01	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:THTX	Theratechnologies Inc
2024/02/21	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/21	21 : 30	GlobeNewswire Inc.	Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance	NASDAQ:THTX	Theratechnologies Inc
2024/02/20	21 : 30	GlobeNewswire Inc.	Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action	NASDAQ:THTX	Theratechnologies Inc
2024/02/15	22 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/15	21 : 30	GlobeNewswire Inc.	Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer	NASDAQ:THTX	Theratechnologies Inc
2024/02/07	04 : 29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/06	21 : 30	GlobeNewswire Inc.	Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update	NASDAQ:THTX	Theratechnologies Inc
2024/02/02	01 : 50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/01/25	03 : 52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc

Showing the most relevant articles for your search:NASDAQ:THTX

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

JP Morgan Chase

Health Care Select Sector

Invesco QQQ Trust Series 1

Financial Select Sector

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約